Data shows CancerIQ Reach closes gap between eligibility and participation in payer-supported, standard and supplemental screenings, leads to early cancer diagnoses and promotes health system loyalty

ICYMI: July's highlight was our webinar with @NebraskaMed's Cancer Survivorship & Risk & Prevention Director Rachael Schmidt, APRN: "What is Campaign-Based Risk Assessment & How Does It Drive Cancer Screening Compliance?" https://t.co/WhxEbGmJq1 #precisionprevention #lungcancer

Beyond traditional clinic settings, there lies a vast opportunity to connect with individuals who might not be aware of their cancer risk or precision prevention opportunities. Learn more about CancerIQ's campaign-based screening: https://t.co/PiUKBrLt4a #precisionprevention

Congratulations to our #CASTUS portfolio company, @CancerIQ, for being named one of the World's Best Digital Health Companies in 2024 by @Newsweek and @StatistaCharts! 🎉 Read full article: https://t.co/jbnM1Ig5Yd #ClevelandAvenue #NewsWeek #AheadOfCancer

CancerIQ seeks health system participants in large-scale research effort: "Validating Applications for Long-term Utility and Enhanced ROI" (VALUE) in Cancer Risk Programs Study, to document the ROI of digital interventions for genetically informed care. https://t.co/KcYYAyXWb9

For #LynchSyndromeAwarenessDay this is your reminder that: 💠 Lynch syndrome is common (1:279 individuals) 💠 Lynch syndrome is actionable (increased surveillance/prevention options lead to better outcomes) 💠 Lynch syndrome is underdiagnosed (most people are not aware that they

There's nothing sweeter than saving lives through #precisionprevention, #earlydetection, and treatment! Happy Valentine's Day from team CancerIQ to every provider using genetic information to empower patients and get #aheadofcancer! Learn more: https://t.co/GO4x3eDEtC

CancerIQ believes that everyone, regardless of where they live, deserves the chance to prevent, detect & treat cancer effectively. Help us make our mission a reality by joining our team. https://t.co/nGL9N68vvQ #WorldCancerDay #CloseTheCareGap #AheadOfCancer #PrecisionPrevention

Q&A: Partnering with providers for #cancer #prevention - @CancerIQ provides personalized care plans to help providers detect cancer early and prevent progression of the disease, says Feyi Ayodele, founder and CEO of CancerIQ.

The American Cancer Society Cancer Facts & Figures 2024 report is here. With breast, prostate, colorectal (ages 0-54), and cervical (ages 30-44) cancers on the rise, it's important to get screened. Hear more from @AmerCancerCEO. Full report: https://t.co/uvqeomlJSv

A much larger pool of patients now requires access to #genetictesting given @ASCO's expanded BRCA1/2 mutation testing recommendations for all #bscm patients <65 years old. It's imperative we equip clinical teams with the tools to support increased volumes.

New germline genetic testing guidelines: All women with breast cancer diagnosis under the age of 65 should be offered germline genetic testing. They don’t need to meet any additional criteria. Thank you @ASCO for the opportunity to draft these guidelines. https://t.co/94nBzqvkQr

Happy, Healthy New Year 2024 from all of us at CancerIQ! Together, we can stay ahead of cancer, bringing hope and health to our communities. Here's to a year of breakthroughs, health, and progress! #aheadofcancer #precisionprevention

1/ Welcome to #CGAIGCJS November Tweetorial on the Making #Genetic Testing Accessible (MAGENTA) Trial by #CGAIGC Comms Cttee member @asafmaoz ➡️The full article from @JAMAOnc can be found at 👉 https://t.co/jxf6gNnzG5 🧵 #HereditaryGICancer

.@CancerX is conducting its first demonstration project to merge data assets, and collaborating with industry partners (including @CancerIQ!) to build comprehensive real-world datasets in a way that’s never been done before in oncology. Learn more:

A new study co-authored by @CatharineWang, @BUSPH and Haibo Lu, @CancerIQ shows point-of-care genetics may improve access, uptake, and reduce racial disparities across broad patient populations. #SABCS23 #BCSM #GeneChat https://t.co/rQZhPJ8QW4

We're thrilled to announce @AssuranceLab SOC 2 Type 2 Compliance, demonstrating that we have undergone rigorous testing & are a trusted platform for empowering health systems to scale genetically informed cancer prevention, treatment, & survivorship care. https://t.co/DVPp9qZWRK

Patient advocate @ARosen380 at @AmericanCancer shares her story & the importance of a #precisionprevention approach for high-risk patient management: "Having Crohn’s disease put me at greater risk for colorectal cancer & as a result, every year, I have a diagnostic colonoscopy."

Today is #GeneticCounselorAwarenessDay! At CancerIQ, we are grateful for the essential role cancer genetic counselors play in helping patients precisely treat, predict, pre-empt, and prevent this disease. https://t.co/nZFXF7l9UJ #GeneChat #AheadOfCancer #PrecisionPrevention

When the #BreastCancerAwarenessMonth pink is packed away, many women don't think about their prevention plans again until next year. Learn how CancerIQ can help you identify, assess, & manage the high-risk patients that need more than an annual screening. https://t.co/asjycZ5PAy